The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.
Ten years ago the documentary "Alive Inside" showed what music can do for dementia patients.In the film, a 90-year-old woman apologizes for her inability to recall events. "I can't remember anymore," ...